A Study of the Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Participants With Episodic Migraine (MK-6096-020)
Clinical trial NCT01513291 · COMPLETED
Trial details
- NCT number
- NCT01513291
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-06
- Primary completion
- 2012-10-03
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.